Pieris inks res­pi­ra­to­ry part­ner­ship with Genen­tech, adding an­oth­er to slate of mile­stone-heavy deals

Four years af­ter strik­ing an up to $2 bil­lion res­pi­ra­to­ry part­ner­ship with As­traZeneca, Pieris Phar­ma­ceu­ti­cals has added an­oth­er deal with a mar­quee phar­ma part­ner …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER